+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Commercial Biotechnology Separation Systems - Global Market Trajectory & Analytics

  • ID: 3619383
  • Report
  • April 2021
  • Region: Global
  • 196 pages
  • Global Industry Analysts, Inc
Global Commercial Biotechnology Separation Systems Market to Reach $31 Billion by 2027

Amid the COVID-19 crisis, the global market for Commercial Biotechnology Separation Systems estimated at US$24.5 Billion in the year 2020, is projected to reach a revised size of US$31 Billion by 2027, growing at a CAGR of 3.4% over the analysis period 2020-2027. DNA Microarray, one of the segments analyzed in the report, is projected to record a 6.5% CAGR and reach US$7.7 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Liquid Chromatography segment is readjusted to a revised 2.4% CAGR for the next 7-year period.

The U.S. Market is Estimated at $6.6 Billion, While China is Forecast to Grow at 6.8% CAGR

The Commercial Biotechnology Separation Systems market in the U.S. is estimated at US$6.6 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2027 trailing a CAGR of 6.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 0.8% and 2.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Flow Cytometry Segment to Record 3.5% CAGR

In the global Flow Cytometry segment, USA, Canada, Japan, China and Europe will drive the 3% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$3.6 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.3 Billion by the year 2027, while Latin America will expand at a 4.4% CAGR through the analysis period.

Select Competitors (Total 46 Featured):
  • 3M Company
  • AB Sciex
  • Agilent Technologies, Inc.
  • Alfa Laval AB
  • Alfa Wassermann Separation Technologies LLC
  • Beckman Coulter Inc.
  • Becton Dickinson and Company
  • Bio-Rad Laboratories Inc.
  • Flottweg SE
  • Fluidigm Corporation
  • GE Healthcare
  • Hitachi High-Technologies Corp.
  • Illumina Inc.
  • Merck KGaA
  • Pall Corporation
  • PerkinElmer Inc.
  • ProMetic Life Sciences Inc.
  • Repligen Corporation
  • Sartorius Stedim Biotech SA
  • Shimadzu Scientific Instruments
  • Sysmex Partec GmbH
  • Thermo Fischer Scientific Inc.
Note: Product cover images may vary from those shown
I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Separation Technologies Drive Biotechnology Industry
  • Recent Market Activity
  • Developed Markets Lead the Way while Emerging Markets Promise Growth
  • DNA Microarrays - Largest & Fastest Growing Segment
  • Liquid Chromatography - One of the Leading Biotechnology Separation Technologies
  • Factors Sustaining Market Growth
  • Factors Restraining Growth
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
  • 3M (USA)
  • AB Sciex LLC (USA)
  • Agilent Technologies, Inc. (USA)
  • Alfa Laval AB (Sweden)
  • Alfa Wassermann Separation Technologies, LLC (USA)
  • Beckman Coulter, Inc. (USA)
  • Becton, Dickinson and Company (USA)
  • Bio-Rad Laboratories, Inc. (USA)
  • Flottweg SE (Germany)
  • Fluidigm Corporation (USA)
  • GE Healthcare (USA)
  • Groupe Novasep (France)
  • Hitachi High-Technologies Corp. (Japan)
  • Illumina, Inc. (USA)
  • Merck KGaA (Germany)
  • Pall Corporation (USA)
  • PerkinElmer, Inc. (USA)
  • ProMetic Life Sciences, Inc. (Canada)
  • Repligen Corporation (USA)
  • Sartorius Stedim Biotech SA (France)
  • SEPMAG (Spain)
  • Shimadzu Scientific Instruments (USA)
  • Sysmex Partec GmbH (Germany)
  • Thermo Fisher Scientific, Inc. (USA)
3. MARKET TRENDS & DRIVERS
  • Bioseparation Systems - Invaluable Tools in Biopharmaceutical Manufacturing
  • A Peek into Biopharmaceutical Manufacturing
  • Downstream Processing of Biosynthetic Products - An Overview
  • Surging Biopharmaceutical Market Spurs Demand for Bioseparation Systems
  • New Biologic License Application (BLA) Approvals: 2017
  • New Biologic License Application (BLA) Approvals: 2016
  • New Biologic License Application (BLA) Approval: 2015
  • Evolving Biopharmaceutical Industry Emphasizes on Novel Technologies
  • Increasing Emphasis on Personalized Medicine Drives Market Growth
  • Rise in Healthcare Spending Bodes Well for Market Growth
  • Aging Population Drives Biotechnology Separation Systems Market
  • Global Aging Population Statistics - Opportunity Indicators
  • Increasing Incidence of Cancer Drives Biotechnology Separation Systems Market
  • Increasing Competition Spurs Renewed Focus on Efficiencies
  • Growing Orphan Drugs Market Draws Attention towards Manufacturing Flexibility
  • Downstream Processing - A Major Trend among Biopharmaceutical Manufacturers
  • Upstream and Downstream Mismatch Turns Focus towards Innovative Technologies
  • Protein Separation in Biopharmaceutical Space Assumes Greater Significance
  • Growing Market for Monoclonal Antibodies - A Key Review of Current Status and Future Prospects
  • Approved Monoclonal Antibodies: 2014-2017
  • An Insight into Bioseparation of mAbs
  • Market Potential for Biosimilars - A Case for Substantial Demand for Separation Technologies
  • US Approved Biosimilars as of December 2017
  • Europe Approved Biosimilars as of December 2017
  • Patent Expiries Create Opportunities for Biosimilar Manufacturers
  • Patent Expiries of Major Biologics in the US and Europe
  • Huge Biopharmaceutical Pipeline - A Clear Indicator of Future Prospects
  • Disposables to Infuse Cost Effectiveness in Biopharmaceutical Production
  • Single-Use Products Gain Significant Attention
  • Market Prospects for Single-Use Disposable Technologies
  • Select Commercial Disposable/Single-Use Technologies by Process Technique
  • Innovations in Single-use Systems
  • Modular Bioprocessing - An Emerging Trend
  • Leachables and Extractables Trounce Enthusiasm around Disposables
4. GLOBAL MARKET PERSPECTIVE

III. MARKET ANALYSIS
  • UNITED STATES
  • CANADA
  • JAPAN
  • CHINA
  • EUROPE
  • FRANCE
  • GERMANY
  • ITALY
  • UNITED KINGDOM
  • SPAIN
  • RUSSIA
  • REST OF EUROPE
  • ASIA-PACIFIC
  • AUSTRALIA
  • INDIA
  • SOUTH KOREA
  • REST OF ASIA-PACIFIC
  • LATIN AMERICA
  • ARGENTINA
  • BRAZIL
  • MEXICO
  • REST OF LATIN AMERICA
  • MIDDLE EAST
  • IRAN
  • ISRAEL
  • SAUDI ARABIA
  • UNITED ARAB EMIRATES
  • REST OF MIDDLE EAST
  • AFRICA
IV. COMPETITION
  • Total Companies Profiled: 46
Note: Product cover images may vary from those shown
Adroll
adroll